JP2007511504A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007511504A5 JP2007511504A5 JP2006539065A JP2006539065A JP2007511504A5 JP 2007511504 A5 JP2007511504 A5 JP 2007511504A5 JP 2006539065 A JP2006539065 A JP 2006539065A JP 2006539065 A JP2006539065 A JP 2006539065A JP 2007511504 A5 JP2007511504 A5 JP 2007511504A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- aryl
- heteroaryl
- heterocycle
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001072 heteroaryl group Chemical group 0.000 claims 84
- 125000000623 heterocyclic group Chemical group 0.000 claims 55
- 125000003118 aryl group Chemical group 0.000 claims 44
- 125000003107 substituted aryl group Chemical group 0.000 claims 44
- 125000000217 alkyl group Chemical group 0.000 claims 42
- 125000003342 alkenyl group Chemical group 0.000 claims 27
- 125000000304 alkynyl group Chemical group 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000002252 acyl group Chemical group 0.000 claims 15
- 125000000547 substituted alkyl group Chemical group 0.000 claims 13
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 12
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000005741 alkyl alkenyl group Chemical group 0.000 claims 12
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 12
- 125000004414 alkyl thio group Chemical group 0.000 claims 12
- -1 alkylalkynyl Chemical group 0.000 claims 12
- 125000004104 aryloxy group Chemical group 0.000 claims 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims 12
- 229910052736 halogen Inorganic materials 0.000 claims 12
- 150000002367 halogens Chemical group 0.000 claims 12
- 125000004404 heteroalkyl group Chemical group 0.000 claims 12
- 150000002431 hydrogen Chemical group 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 239000001257 hydrogen Substances 0.000 claims 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 12
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 12
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 12
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 150000001721 carbon Chemical group 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 3
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 101000869592 Daucus carota Major allergen Dau c 1 Proteins 0.000 claims 2
- 101000650136 Homo sapiens WAS/WASL-interacting protein family member 3 Proteins 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 101000585507 Solanum tuberosum Cytochrome b-c1 complex subunit 7 Proteins 0.000 claims 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 2
- 102100027539 WAS/WASL-interacting protein family member 3 Human genes 0.000 claims 2
- 201000010881 cervical cancer Diseases 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000012010 growth Effects 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 208000014018 liver neoplasm Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 210000005170 neoplastic cell Anatomy 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 208000032271 Malignant tumor of penis Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000002471 Penile Neoplasms Diseases 0.000 claims 1
- 206010034299 Penile cancer Diseases 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000009826 neoplastic cell growth Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
- 0 Cc1c(*)nc(*)[n]1* Chemical compound Cc1c(*)nc(*)[n]1* 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52027903P | 2003-11-14 | 2003-11-14 | |
| US60/520,279 | 2003-11-14 | ||
| US59950904P | 2004-08-06 | 2004-08-06 | |
| US60/599,509 | 2004-08-06 | ||
| PCT/IB2004/052433 WO2005047266A1 (en) | 2003-11-14 | 2004-11-15 | Aryl imidazoles and their use as anti-cancer agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007511504A JP2007511504A (ja) | 2007-05-10 |
| JP2007511504A5 true JP2007511504A5 (https=) | 2007-12-27 |
| JP5095216B2 JP5095216B2 (ja) | 2012-12-12 |
Family
ID=34594988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006539065A Expired - Fee Related JP5095216B2 (ja) | 2003-11-14 | 2004-11-15 | アリールイミダゾールおよびその抗癌剤としての使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8969372B2 (https=) |
| EP (1) | EP1692113B1 (https=) |
| JP (1) | JP5095216B2 (https=) |
| AU (1) | AU2004289539C1 (https=) |
| CA (1) | CA2545942C (https=) |
| DK (1) | DK1692113T3 (https=) |
| WO (1) | WO2005047266A1 (https=) |
Families Citing this family (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003257329C1 (en) | 2002-08-19 | 2010-07-22 | Lorus Therapeutics Inc. | 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| TWI372050B (en) | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
| US8969372B2 (en) * | 2003-11-14 | 2015-03-03 | Aptose Boisciences Inc. | Aryl imidazoles and their use as anti-cancer agents |
| WO2005061519A1 (en) | 2003-12-19 | 2005-07-07 | Takeda San Diego, Inc. | Kinase inhibitors |
| EP1778669A2 (en) | 2004-08-18 | 2007-05-02 | Takeda San Diego, Inc. | Kinase inhibitors |
| ATE479687T1 (de) | 2004-10-15 | 2010-09-15 | Takeda Pharmaceutical | Kinaseinhibitoren |
| US7442716B2 (en) * | 2004-12-17 | 2008-10-28 | Merck Frosst Canada Ltd. | 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors |
| EP1833819A1 (en) | 2004-12-30 | 2007-09-19 | Astex Therapeutics Limited | Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| JP5334575B2 (ja) * | 2005-05-25 | 2013-11-06 | ローラス セラピューティクス インコーポレーテッド | ２−インドリルイミダゾ［４，５‐ｄ］フェナントロリン派生物および癌治療におけるそれらの使用 |
| AU2006250809B2 (en) | 2005-05-25 | 2011-05-12 | Lorus Therapeutics Inc. | 2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer |
| US8703805B2 (en) * | 2005-06-27 | 2014-04-22 | Exelixis Patent Company Llc | Modulators of LXR |
| SG162803A1 (en) * | 2005-06-27 | 2010-07-29 | Exelixis Inc | Imidazole based lxr modulators |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| EP1968579A1 (en) | 2005-12-30 | 2008-09-17 | Astex Therapeutics Limited | Pharmaceutical compounds |
| EP2019675A4 (en) * | 2006-05-02 | 2011-03-02 | Merck Frosst Canada Ltd | METHOD FOR THE TREATMENT OR PREVENTION OF NEOPLASIA |
| EP2049119A2 (en) | 2006-06-29 | 2009-04-22 | Astex Therapeutics Limited | Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morphoolin-4-ylmethyl-1h-benzoimidazol-2-yl)-1h-1-pyrazol-4-yl]-urea |
| US20080090834A1 (en) * | 2006-07-06 | 2008-04-17 | Pfizer Inc | Selective azole pde10a inhibitor compounds |
| SG158147A1 (en) | 2006-10-09 | 2010-01-29 | Takeda Pharmaceutical | Kinase inhibitors |
| KR20090094125A (ko) | 2006-12-08 | 2009-09-03 | 엑셀리시스, 인코포레이티드 | Ｌｘｒ 및 ｆｘｒ 조절자 |
| KR101090850B1 (ko) * | 2007-02-26 | 2011-12-08 | 연세대학교 산학협력단 | Ｈｓｃ７０ 저해제로서의 이미다졸 유도체와 그 약학적 조성물 |
| CN101130539B (zh) * | 2007-09-26 | 2012-05-30 | 浙江大学 | 吲哚取代咪唑啉-2-酮类衍生物及其制备方法和用途 |
| AU2009227013B2 (en) * | 2008-03-21 | 2013-01-10 | Novartis Ag | Novel heterocyclic compounds and uses therof |
| US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
| CN102361857B (zh) | 2008-09-26 | 2015-09-16 | 默沙东公司 | 可用作抗糖尿病剂的环状苯并咪唑衍生物 |
| WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
| WO2010102393A1 (en) * | 2009-03-12 | 2010-09-16 | Lorus Therapeutics Inc. | 2-indolyl imidazo [4,5-d]phenanthroline derivatives and their use to inhibit angiogenesis |
| KR101676704B1 (ko) * | 2009-05-28 | 2016-11-16 | 엑셀리시스 페이턴트 컴퍼니 엘엘씨 | Ｌｘｒ 조절자 |
| EP2987487B1 (en) | 2009-08-10 | 2020-10-07 | Samumed, LLC | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| JO3002B1 (ar) | 2009-08-28 | 2016-09-05 | Irm Llc | مركبات و تركيبات كمثبطات كيناز بروتين |
| CN101735217B (zh) * | 2009-12-15 | 2012-09-26 | 广东药学院 | 咪唑[4,5-f][1,10]菲咯啉及其衍生物在制备抗肿瘤药物中的应用 |
| EP2515655B1 (en) | 2009-12-21 | 2015-08-05 | Samumed, LLC | 1h-pyrazolo[3,4-beta]pyridines and therapeutic uses thereof |
| US8895596B2 (en) | 2010-02-25 | 2014-11-25 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| WO2012033149A1 (ja) | 2010-09-10 | 2012-03-15 | 塩野義製薬株式会社 | Ａｍｐｋ活性化作用を有するヘテロ環縮合イミダゾール誘導体 |
| DE102011009961A1 (de) | 2011-02-01 | 2012-08-02 | Merck Patent Gmbh | 7-Azaindolderivate |
| EP3473099A1 (en) | 2011-09-14 | 2019-04-24 | Samumed, LLC | Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors |
| CN108542906A (zh) | 2011-11-11 | 2018-09-18 | 诺华股份有限公司 | 治疗增生性疾病的方法 |
| PH12017500997A1 (en) | 2012-04-04 | 2018-02-19 | Samumed Llc | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| EP2770994B1 (en) | 2012-05-04 | 2019-08-21 | Samumed, LLC | 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| WO2014110086A2 (en) | 2013-01-08 | 2014-07-17 | Samumed, Llc | 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof |
| US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
| WO2014153464A2 (en) * | 2013-03-20 | 2014-09-25 | Lorus Therapeutics Inc. | 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| ES2775579T3 (es) | 2013-10-04 | 2020-07-27 | Aptose Biosciences Inc | Composiciones para el tratamiento del cáncer |
| KR102359214B1 (ko) | 2014-04-04 | 2022-02-07 | 델 마 파마슈티컬스 | 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체 |
| WO2016040193A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
| WO2016040181A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
| WO2016040188A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
| WO2016040185A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof |
| WO2016040190A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
| WO2016040184A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
| WO2016040182A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof |
| WO2016040180A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
| UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
| WO2016086022A2 (en) * | 2014-11-26 | 2016-06-02 | Channel Therapeutics, Inc. | Heteroaromatic imidazolyl compounds and methods for treating cancer |
| US10844051B2 (en) | 2015-07-22 | 2020-11-24 | The Royal Institution For The Advancement Of Learning/Mcgill University | Substituted oxazoles for the treatment of cancer |
| US10166218B2 (en) | 2015-08-03 | 2019-01-01 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
| WO2017023989A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
| WO2017023972A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
| US10206908B2 (en) | 2015-08-03 | 2019-02-19 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
| WO2017023975A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
| WO2017023996A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| US10226448B2 (en) | 2015-08-03 | 2019-03-12 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof |
| US10206909B2 (en) | 2015-08-03 | 2019-02-19 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| US10350199B2 (en) | 2015-08-03 | 2019-07-16 | Samumed, Llc | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
| WO2017024010A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
| US10519169B2 (en) | 2015-08-03 | 2019-12-31 | Samumed, Llc | 3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| US10285982B2 (en) | 2015-08-03 | 2019-05-14 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
| US10188634B2 (en) | 2015-08-03 | 2019-01-29 | Samumed, Llc | 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| US10329309B2 (en) | 2015-08-03 | 2019-06-25 | Samumed, Llc | 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| WO2017024003A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
| US10226453B2 (en) | 2015-08-03 | 2019-03-12 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| US10604512B2 (en) | 2015-08-03 | 2020-03-31 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof |
| BR112018009252A2 (pt) | 2015-11-06 | 2018-11-06 | Samumed Llc | tratamento da osteoartrite |
| AR108325A1 (es) | 2016-04-27 | 2018-08-08 | Samumed Llc | Isoquinolin-3-il carboxamidas y preparación y uso de las mismas |
| LT3464285T (lt) | 2016-06-01 | 2022-12-27 | Biosplice Therapeutics, Inc. | N-(5-(3-(7-(3-fluorfenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)- 3-metilbutanamido gamybos būdas |
| CN106220612A (zh) * | 2016-08-10 | 2016-12-14 | 大连理工大学 | 一类含吲哚的菲并[9,10‑d]咪唑类衍生物及其合成和应用 |
| AU2017329090B9 (en) | 2016-09-19 | 2019-09-05 | Novartis Ag | Therapeutic combinations comprising a RAF inhibitor and a ERK inhibitor |
| CN110709082A (zh) | 2016-10-21 | 2020-01-17 | 萨穆梅德有限公司 | 吲唑-3-甲酰胺的使用方法及其作为Wnt/β-连环蛋白信号传导途径抑制剂的用途 |
| US10758523B2 (en) | 2016-11-07 | 2020-09-01 | Samumed, Llc | Single-dose, ready-to-use injectable formulations |
| ES2952265T3 (es) | 2017-05-02 | 2023-10-30 | Novartis Ag | Terapia combinada que comprende un inhibidor de Raf y trametinib |
| KR102070879B1 (ko) * | 2017-10-17 | 2020-01-29 | 성균관대학교산학협력단 | Mnpⅱ를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물 |
| CN111417395A (zh) | 2017-10-30 | 2020-07-14 | 艾普托斯生物科学公司 | 用于治疗癌症的芳基咪唑 |
| GB201718285D0 (en) | 2017-11-03 | 2017-12-20 | Discuva Ltd | Antibacterial Compounds |
| SG11202006246PA (en) | 2018-01-17 | 2020-07-29 | Aurigene Discovery Tech Ltd | Substituted alkynylene compounds as anticancer agents |
| AU2020270303B2 (en) | 2019-05-08 | 2023-09-07 | Tyk Medicines, Inc. | Compound used as kinase inhibitor and application thereof |
| ES3025633T3 (en) | 2019-05-13 | 2025-06-09 | Novartis Ag | New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer |
| WO2022249192A1 (en) * | 2021-05-27 | 2022-12-01 | Ramot At Tel-Aviv University Ltd. | Broad-spectrum metastasis suppressing compounds and therapeutic uses thereof in human tumors |
| CN116554126B (zh) * | 2023-04-18 | 2025-04-18 | 兰州大学 | 一种靶向降解cdk6的化合物及应用 |
Family Cites Families (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE585555A (https=) | 1960-03-31 | |||
| US3297710A (en) | 1963-04-09 | 1967-01-10 | Du Pont | Oxoarylidene-imidazoles |
| US3714181A (en) | 1970-12-31 | 1973-01-30 | American Cyanamid Co | 2-aryl-5,10-diphenylphenanthro(9,10-d)azoles |
| US4089747A (en) | 1976-08-09 | 1978-05-16 | Eastman Kodak Company | Compositions for the detection of hydrogen peroxide |
| US4535058A (en) | 1982-10-01 | 1985-08-13 | Massachusetts Institute Of Technology | Characterization of oncogenes and assays based thereon |
| DE3141063A1 (de) | 1981-10-13 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| US4423046A (en) | 1982-04-05 | 1983-12-27 | Sterling Drug Inc. | Antibacterial and antiprotozoal 1-methyl-5-nitro-2-(2-phenylvinyl)imidazoles |
| DE3422175A1 (de) | 1984-06-04 | 1985-12-19 | Julius Dr. 8000 München Kern | Verfahren zur beimischung von ammoniak zu saure schadstoffe enthaltenden abgasen oder luft |
| JPS614960A (ja) | 1984-06-19 | 1986-01-10 | Fuji Photo Film Co Ltd | 分析試薬および多層化学分析要素 |
| US4762706A (en) | 1984-10-17 | 1988-08-09 | Cetus Corporation | Peptide antibodies and their use in detecting oncogene products |
| US5081230A (en) | 1987-07-08 | 1992-01-14 | E. I. Dupont Denemours And Company | Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein |
| US5443956A (en) | 1985-01-29 | 1995-08-22 | Oncogene Science, Inc. | Detection, quantitation and classification of RAS proteins in body fluids and tissues |
| US4720459A (en) | 1985-02-14 | 1988-01-19 | Medical College Of Wisconsin Research Foundation, Inc. | Myelomas for producing human/human hybridomas |
| US4758421A (en) | 1985-03-15 | 1988-07-19 | The Board Of Trustees Of The Leland Stanford Junior University | Bleomycin conjugates and method |
| IT1214597B (it) | 1985-04-15 | 1990-01-18 | Rorer Italiana Spa | Derivati dell'imidazolo adattivita' antimicotica, procedimento ed intermedi per laloro preparazione e composizioni che li contengono. |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4902705A (en) | 1985-12-12 | 1990-02-20 | Ube Industries, Ltd. | Imidazole derivatives, an antibacterial and antifungal agent comprising said derivatives, and a process for the production of said imidazole derivatives |
| US5024935A (en) | 1987-12-18 | 1991-06-18 | Eastman Kodak Company | Dye-providing composition, diagnostic test kit and their use in method for ligand determination using peroxidase labeled-receptor |
| US5047318A (en) | 1988-06-13 | 1991-09-10 | Eastman Kodak Company | Imidazole leuco dye composition containing 4'-hydroxyacetanilide, diagnostic kit and method using same |
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| US5501959A (en) | 1989-01-17 | 1996-03-26 | Alamar Biosciences Laboratory, Inc. | Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents |
| US5514550A (en) | 1989-02-03 | 1996-05-07 | Johnson & Johnson Clinical Diagnostics, Inc. | Nucleic acid test article and its use to detect a predetermined nucleic acid |
| US5441716A (en) | 1989-03-08 | 1995-08-15 | Rocky Research | Method and apparatus for achieving high reaction rates |
| ATE122256T1 (de) | 1989-03-08 | 1995-05-15 | Rocky Research | Vorrichtung und verfahren zur erhaltung von hohen reaktionsleistungen in fest-gas-reaktorsystemen. |
| JPH02258017A (ja) | 1989-03-31 | 1990-10-18 | Babcock Hitachi Kk | 固体還元剤を用いた排ガス脱硝装置 |
| US4970226A (en) | 1989-10-03 | 1990-11-13 | Harbor Branch Oceanographic Institution, Inc. | Bis-indole imidazole compounds which are useful antitumor and antimicrobial agents |
| US5161389A (en) | 1990-11-13 | 1992-11-10 | Rocky Research | Appliance for rapid sorption cooling and freezing |
| US5656644A (en) | 1994-07-20 | 1997-08-12 | Smithkline Beecham Corporation | Pyridyl imidazoles |
| US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
| MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| WO1995003297A1 (en) | 1993-07-21 | 1995-02-02 | Smithkline Beecham Corporation | Imidazoles for treating cytokine mediated disease |
| US5496702A (en) | 1994-09-01 | 1996-03-05 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassay elements having stable leuco dye coatings |
| DK0797575T3 (da) | 1994-12-13 | 2004-02-16 | Hoffmann La Roche | Imidazolderivater som proteinkinase-inhibitorer, især EGF-R-tyrosinkinase |
| TW424172B (en) | 1995-04-19 | 2001-03-01 | Hitachi Chemical Co Ltd | Photosensitive resin composition and photosensitive element using the same |
| US5700826A (en) | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
| US5753687A (en) | 1995-06-19 | 1998-05-19 | Ontogen Corporation | Modulators of proteins with phosphotryrosine recognition units |
| CA2250232A1 (en) | 1996-04-03 | 1997-10-09 | Allen I. Oliff | A method of treating cancer |
| US5693589A (en) | 1996-05-08 | 1997-12-02 | Eastman Kodak Company | Thermal imaging recording element |
| EP0812829A1 (en) * | 1996-06-14 | 1997-12-17 | Ontogen Corporation | Substituted imidazoles as modulators of multi-drug resistance |
| IT240917Y1 (it) | 1996-10-01 | 2001-04-11 | Stefcom Spa | Scarpa con tomaia avente porzione per la traspirazione dell'internodella scarpa |
| EP0946587A2 (en) | 1996-12-16 | 1999-10-06 | Fujisawa Pharmaceutical Co., Ltd. | New amide compounds |
| CA2275610A1 (en) * | 1996-12-16 | 1998-06-25 | Ontogen Corporation | Modulators of proteins with phosphotyrosine recognition units |
| US5945418A (en) | 1996-12-18 | 1999-08-31 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
| US5809775A (en) | 1997-04-02 | 1998-09-22 | Clean Diesel Technologies, Inc. | Reducing NOx emissions from an engine by selective catalytic reduction utilizing solid reagents |
| RU2222534C2 (ru) | 1997-04-24 | 2004-01-27 | Орто-Макнейл Фармасьютикал, Инк. | Замещенные имидазолы, способ их получения, фармацевтическая композиция на их основе, способы лечения цитокин-опосредованных заболеваний |
| JPH10319584A (ja) | 1997-05-21 | 1998-12-04 | Brother Ind Ltd | マイクロカプセルを用いた感光性記録材料 |
| HUP0003934A3 (en) | 1997-07-03 | 2002-01-28 | Pfizer | A part of diaryl imidazole derivatives, pharmaceutical composit |
| DE19728343C5 (de) | 1997-07-03 | 2013-02-21 | Robert Bosch Gmbh | Verfahren und Vorrichtung zur selektiven katalytischen NOx-Reduktion |
| US5840721A (en) * | 1997-07-09 | 1998-11-24 | Ontogen Corporation | Imidazole derivatives as MDR modulators |
| US6329375B1 (en) | 1997-08-05 | 2001-12-11 | Sugen, Inc. | Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors |
| GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
| JPH11199582A (ja) | 1998-01-05 | 1999-07-27 | Sagami Chem Res Center | ４（５）−（３−インドリル）イミダゾール誘導体 |
| US5915891A (en) | 1998-02-17 | 1999-06-29 | Fridman; Yevgeny Z. | Drill guide and method for installing a door lock |
| JP2002506855A (ja) | 1998-03-18 | 2002-03-05 | ウェイク フォレスト ユニヴァーシティ | 細胞毒性金属キレート剤とその製法及びその使用方法 |
| US6288212B1 (en) | 1998-08-28 | 2001-09-11 | The University Of British Columbia | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| AU2164300A (en) | 1998-12-04 | 2000-06-26 | N.V. Organon | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
| JP2000273088A (ja) | 1999-01-18 | 2000-10-03 | Nippon Soda Co Ltd | トリフェニルイミダゾール化合物および農園芸用殺菌剤 |
| JP2000281588A (ja) * | 1999-03-30 | 2000-10-10 | Sankyo Co Ltd | ガンの予防又は治療薬及びそのスクリーニング方法 |
| DE19920936A1 (de) | 1999-05-07 | 2000-11-09 | Basf Ag | Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung |
| AU4640600A (en) | 1999-05-11 | 2000-11-21 | Eli Lilly And Company | Amyloid precursor protein protease and related nucleic acid compounds |
| US7364868B2 (en) | 1999-05-19 | 2008-04-29 | The Uab Research Foundation | Krüppel-like transcriptional factor KLF4/GKLF and uses thereof |
| DE19925631A1 (de) | 1999-06-04 | 2000-12-07 | Georg Gros | Beschichtungsverfahren und Beschichtungsgemisch |
| AU5886500A (en) * | 1999-06-23 | 2001-01-09 | Sepracor, Inc. | Indolyl-benzimidazole antibacterials, and methods of use thereof |
| US6266955B1 (en) | 1999-08-20 | 2001-07-31 | Caterpillar Inc. | Diagnostic system for an emissions control on an engine |
| CN1087744C (zh) * | 1999-09-24 | 2002-07-17 | 中国科学院化学研究所 | 一种钌（ⅱ）多吡啶配合物及其制备方法 |
| CN1088713C (zh) * | 1999-09-24 | 2002-08-07 | 中国科学院化学研究所 | 用于二级pH传感的钌（Ⅱ）多吡啶配合物及其制备方法 |
| EP2064951A1 (en) * | 1999-10-08 | 2009-06-03 | Taiji Biomedical, Inc. | Use of a substituted imidazole, derivatives or salts thereof for the preparation of a medicament for the treatment of a cell proliferative disorder |
| US7115645B2 (en) | 2000-01-14 | 2006-10-03 | Schering Aktiengesellschaft | 1,2 diarylbenzimidazoles and their pharmaceutical use |
| AU2001249548A1 (en) | 2000-03-27 | 2001-10-08 | Thomas Jefferson University | Compositions and methods for identifying and targeting cancer cells |
| US7199137B2 (en) * | 2000-09-21 | 2007-04-03 | Smithkline Beecham Plc | Imidazole derivatives as Raf kinase inhibitors |
| JP4162994B2 (ja) | 2000-10-13 | 2008-10-08 | ヴァイオン ファーマシューティカルズ， インコーポレイテッド | 諸疾患状態の処置のための薬物に使用する化合物とその製造方法 |
| US20070004713A1 (en) | 2000-12-07 | 2007-01-04 | Bernard Barlaam | Therapeutic benimidazole compounds |
| CA2440211A1 (en) * | 2001-03-09 | 2002-09-19 | Pfizer Products Inc. | Benzimidazole anti-inflammatory compounds |
| JP2002275458A (ja) | 2001-03-21 | 2002-09-25 | Fukuoka Prefecture | フォトクロミックアモルファス材料及び高密度光記録媒体 |
| WO2002083111A2 (en) | 2001-04-16 | 2002-10-24 | Tanabe Seiyaku Co., Ltd. | Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| US6916440B2 (en) | 2001-05-31 | 2005-07-12 | 3M Innovative Properties Company | Processes and apparatus for making transversely drawn films with substantially uniaxial character |
| JP3759882B2 (ja) | 2001-06-01 | 2006-03-29 | 株式会社日立製作所 | ポンプ装置 |
| DE10134775A1 (de) | 2001-07-06 | 2003-01-30 | Schering Ag | 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate |
| US7695926B2 (en) | 2001-07-10 | 2010-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting receptor-ligand interactions in single cells |
| EP1414443B1 (en) | 2001-08-01 | 2006-11-15 | Merck & Co., Inc. | BENZIMIDAZO 4,5-f|ISOQUINOLINONE DERIVATIVES |
| EP1435947B1 (en) | 2001-10-19 | 2007-08-15 | Ortho-McNeil Pharmaceutical, Inc. | 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| JP2005517007A (ja) * | 2002-02-07 | 2005-06-09 | アクシス・ファーマスーティカルズ | ヒストンデアセチラーゼ阻害剤としての新規二環式ヒドロキサメート |
| US6790852B2 (en) | 2002-04-18 | 2004-09-14 | Hoffmann-La Roche Inc. | 2-(2,6-dichlorophenyl)-diarylimidazoles |
| CA2482087C (en) * | 2002-06-19 | 2011-04-19 | Kurita Water Industries Ltd. | Method of storing hydrogen, hydrogen inclusion compound and process for producing the same |
| EP1532118A2 (en) | 2002-07-05 | 2005-05-25 | Axxima Pharmaceuticals Aktiengesellschaft | Imidazole compounds for the treatment of hepatitis c virus infections |
| AU2003257329C1 (en) | 2002-08-19 | 2010-07-22 | Lorus Therapeutics Inc. | 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| DE10251472A1 (de) | 2002-11-06 | 2004-05-19 | Robert Bosch Gmbh | Verfahren zur Nachbehandlung von Abgasen und Anordnung hierzu |
| WO2004071464A2 (en) | 2003-02-12 | 2004-08-26 | Johns Hopkins University School Of Medicine | Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| CA2425797C (en) | 2003-04-17 | 2013-10-15 | Xerox Corporation | Organic light emitting devices |
| US7989089B2 (en) | 2003-04-17 | 2011-08-02 | Lg Display Co., Ltd. | Organic luminescent compounds and methods of making and using same |
| DE10323591A1 (de) | 2003-05-16 | 2004-12-02 | E.G.O. Elektro-Gerätebau GmbH | Verfahren und Vorrichtung zur Erzeugung eines Gases aus einem Sublimationsgut |
| US8969372B2 (en) | 2003-11-14 | 2015-03-03 | Aptose Boisciences Inc. | Aryl imidazoles and their use as anti-cancer agents |
| US20050195793A1 (en) | 2004-03-05 | 2005-09-08 | Lockheed Martin Corporation | System for locally synchronizing a group of mobile devices |
| US20050282285A1 (en) | 2004-06-21 | 2005-12-22 | Eaton Corporation | Strategy for controlling NOx emissions and ammonia slip in an SCR system using a nonselective NOx/NH3 |
| JP2008508186A (ja) | 2004-08-03 | 2008-03-21 | アムミネクス・アー／エス | 固体アンモニア貯蔵及び移送材料 |
| WO2006081824A2 (en) | 2005-02-03 | 2006-08-10 | Amminex A/S | High density storage of ammonia |
| AU2006250809B2 (en) | 2005-05-25 | 2011-05-12 | Lorus Therapeutics Inc. | 2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer |
| JP2008546968A (ja) | 2005-06-29 | 2008-12-25 | アムミネクス・アー／エス | 固体アンモニア貯蔵媒体からのアンモニアの安全な制御された送出のための方法および装置 |
| KR100694181B1 (ko) | 2005-11-25 | 2007-03-12 | 연세대학교 산학협력단 | 근원세포 또는 근섬유로부터 신경세포 분화를 유도하는화합물, 이를 포함하는 약학적 조성물, 신경세포 분화를유도하는 방법 및 신경세포 분화를 유도하는 화합물을검색하는 스크리닝 방법 |
| ES2646545T3 (es) | 2006-09-07 | 2017-12-14 | Arthur E. Frankel | Métodos y composiciones basadas en conjugados de toxina diftérica-interleucina-3 |
| WO2008125883A1 (en) | 2007-04-16 | 2008-10-23 | Cancer Research Technology Limited | Cancer markers for prognosis and screening of anti-cancer agents |
| JP5566880B2 (ja) | 2007-04-24 | 2014-08-06 | インゲニウム ファーマシューティカルズ ジーエムビーエイチ | プロテインキナーゼの阻害剤としての４，６−二置換アミノピリミジン誘導体 |
| EP2211870A1 (en) | 2007-11-01 | 2010-08-04 | Celgene Corporation | Cytidine analogs for treatment of myelodysplastic syndromes |
| WO2009151503A2 (en) | 2008-04-10 | 2009-12-17 | University Of Florida Research Foundation, Inc. | Compositions and methods for the treatment of a neoplasia |
| CA2695590C (en) | 2008-06-27 | 2018-01-09 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
| US8399206B2 (en) | 2008-07-10 | 2013-03-19 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
| WO2010102393A1 (en) | 2009-03-12 | 2010-09-16 | Lorus Therapeutics Inc. | 2-indolyl imidazo [4,5-d]phenanthroline derivatives and their use to inhibit angiogenesis |
| ES2413255T3 (es) | 2009-04-09 | 2013-07-16 | Lga Biotecnologie Srl | Determinación de la eficacia de 5-ASA en la prevención y/o el tratamiento de CRC mediante el análisis de la expresión génica |
| ES2571235T3 (es) | 2009-04-10 | 2016-05-24 | Kyowa Hakko Kirin Co Ltd | Procedimiento para el tratamiento de un tumor sanguíneo que utiliza el anticuerpo anti-TIM-3 |
| EP3444333A1 (en) | 2009-10-22 | 2019-02-20 | Thomas Jefferson University | Cell-based anti-cancer compositions and methods of making and using the same |
| US8524240B2 (en) | 2009-10-26 | 2013-09-03 | Djordje Atanackovic | Diagnosis and therapy of hematological malignancies |
| US20130011411A1 (en) | 2010-01-06 | 2013-01-10 | Pestell Richard G | Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| KR101317513B1 (ko) | 2010-05-17 | 2013-10-15 | 가톨릭대학교 산학협력단 | 대장암 또는 난소암 진단용 조성물, 진단키트 및 진단방법 |
| CA2803113A1 (en) | 2010-06-28 | 2012-01-12 | Threshold Pharmaceuticals, Inc. | Treatment of blood cancer |
| US20120172244A1 (en) | 2010-12-20 | 2012-07-05 | Steven Buechler | Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease |
| US9824179B2 (en) | 2011-12-09 | 2017-11-21 | Adaptive Biotechnologies Corp. | Diagnosis of lymphoid malignancies and minimal residual disease detection |
| TW201343920A (zh) | 2012-03-29 | 2013-11-01 | 財團法人國家衛生研究院 | 預測前列腺癌預後之分子標記、方法與套組 |
| ES2775579T3 (es) | 2013-10-04 | 2020-07-27 | Aptose Biosciences Inc | Composiciones para el tratamiento del cáncer |
-
2004
- 2004-11-15 US US10/579,149 patent/US8969372B2/en not_active Expired - Fee Related
- 2004-11-15 AU AU2004289539A patent/AU2004289539C1/en not_active Ceased
- 2004-11-15 DK DK04799154.2T patent/DK1692113T3/en active
- 2004-11-15 JP JP2006539065A patent/JP5095216B2/ja not_active Expired - Fee Related
- 2004-11-15 CA CA2545942A patent/CA2545942C/en not_active Expired - Fee Related
- 2004-11-15 WO PCT/IB2004/052433 patent/WO2005047266A1/en not_active Ceased
- 2004-11-15 EP EP04799154.2A patent/EP1692113B1/en not_active Expired - Lifetime
-
2015
- 2015-01-22 US US14/602,339 patent/US10080739B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007511504A5 (https=) | ||
| CA2545942A1 (en) | Aryl imidazoles and their use as anti-cancer agents | |
| CN115244058A (zh) | 嘧啶并二环类衍生物、其制备方法及其在医药上的应用 | |
| JP2008535902A5 (https=) | ||
| JP2008535903A5 (https=) | ||
| JP2011509949A5 (https=) | ||
| JP2008533191A5 (https=) | ||
| JP2007515413A5 (https=) | ||
| JP2010502730A5 (https=) | ||
| RU2011152891A (ru) | Диарилгидантоины | |
| JP2011524422A5 (https=) | ||
| JP2011526917A5 (https=) | ||
| JP2009515980A5 (https=) | ||
| CN115605479A (zh) | 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2010511721A5 (https=) | ||
| JP2006504658A5 (https=) | ||
| JP2008510828A5 (https=) | ||
| CN102250189A (zh) | 一种具有1,12-二烯-3-酮骨架的甘草次酸衍生物、其制备方法及医药用途 | |
| CA2617991A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| JP2009503110A5 (https=) | ||
| JP2006522824A5 (https=) | ||
| JP2020502116A5 (https=) | ||
| JP2005511594A5 (https=) | ||
| JP2010535706A5 (https=) | ||
| JP2019504833A5 (https=) |